Toni K. Choueiri, MD of the Dana-Farber Cancer Institute discusses the changes in first line kidney cancer treatment for 2018 at the  12th European International Kidney Cancer Symposium 2017
What Change in First Line for 2018 in Kidney Cancer


Toni K. Choueiri, MD of the Dana-Farber Cancer Institute discusses the changes in first line kidney cancer treatment for 2018 at the  12th European International Kidney Cancer Symposium 2017